SCHEMBL25299532

SCHEMBL25299532

CC(C)(C)N(C(=O)O)c1nc2ccc(Nc3cncc(C(F)(F)F)c3)cc2s1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAS2R14 Q9NYV8 1/20 0.43
PIK3CD O00329 1/20 0.41
PPARA Q07869 2/20 0.39
DYRK1A Q13627 1/20 0.39
CSNK1D P48730 3/20 0.38
PPARG P37231 1/20 0.38
KDM4E B2RXH2 1/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
MAPT P10636 4/20 0.36
TP53 P04637 2/20 0.36
LMNA P02545 2/20 0.36
KIF11 P52732 1/20 0.36
CACNA1B Q00975 2/20 0.36
CACNA1H O95180 1/20 0.36
BACE2 Q9Y5Z0 1/20 0.35
XDH P47989 1/20 0.35
SLC22A12 Q96S37 1/20 0.35
NPC1 O15118 1/20 0.35
AR P10275 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25303406 0.83 LIPE (0.44) PPARADYRK1ACSNK1DPPARGKDM4E
SCHEMBL25300412 0.77 IRAK4 (0.39) DYRK1AKDM4EMEN1KMT2AMAPT
SCHEMBL25259089 0.77 PIK3CD (0.50) PIK3CDDYRK1ACSNK1D
SCHEMBL31114491 0.77 PIK3CD (0.50) PIK3CDDYRK1ACSNK1D
SCHEMBL25303578 0.76 NPC1 (0.38) KDM4EMEN1KMT2AMAPTTP53
SCHEMBL2482877 0.72 HTT (0.61) DYRK1A
SCHEMBL3410201 0.71 HTT (0.42) PPARADYRK1ATP53LMNANPC1
SCHEMBL20595677 0.71 PPARA (0.55) PPARADYRK1AKDM4EMAPTLMNA
SCHEMBL25303127 0.71 ALDH1A1 (0.56) PIK3CDDYRK1ACSNK1D
SCHEMBL30450142 0.71 ALDH1A1 (0.56) PIK3CDDYRK1ACSNK1D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250382273-A1 BENZOTHIAZOLE ANAOLOGUES AND USE THEREOF AS BOOSTERS OF ANTI TUBERCULOSIS DRUGS INST NAT SANTE RECH MED (FR) 2025-12-18 US disclosed
WO-2023131649-A1 BENZOTHIAZOLE ANAOLOGUES AND USE THEREOF AS BOOSTERS OF ANTI TUBERCULOSIS DRUGS INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) 2023-07-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250382273-A1 BENZOTHIAZOLE ANAOLOGUES AND USE THEREOF AS BOOSTERS OF ANTI TUBERCULOSIS DRUGS BBOX1, NDUFB6, NDUFB5 TAS2R14 3703/4885PIK3CD 3384/4885PPARA 566/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.